Skip to main content

Table 1 Baseline patients’ characteristics

From: PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome

Characteristics PSMA expression Overall
Negative Positive
Score 0 (n = 12) Score 1 (n = 25) Score 2 (n = 22) N = 59
Age
< 55 years 8 12 13 33
≥ 55 years 4 13 9 26
Sex
 Male 3 6 5 14
 Female 9 19 17 45
Histological DTC subtype
 Well differentiated
  Papillary 12 21 16 49
  Follicular 0 2 2 4
 Poorly differentiated 0 2 4 6
Primary tumor site
 Left lobe 7 8 11 26
 Right lobe 2 13 7 22
 Left lobe + right lobe 2 2 4 8
 Isthmus 0 1 0 1
 Left lobe + isthmus 0 1 0 1
 Right lobe + isthmus 1 0 0 1
TNM
 T1/T2 6 17 10 33
 T3/T4 6 8 12 26
 N0 7 19 12 38
 N+ 5 6 10 21
 M0 12 22 16 50
 M+ 0 3 6 9
Stage
 I/II 12 20 15 47
 III/IV 0 5 7 12
Vascular invasion  
 No 6 16 7 29
 Yes 6 9 15 30
Status of surgical margins
 Free 9 20 16 45
 Involved 3 5 6 14
Recurrence
 No 9 19 12 40
 Yes 3 6 10 19
Radioiodine refractoriness
 No 10 21 16 47
 Yes 2 4 6 12
Status at last follow-up
 No evidence of disease 10 21 15 46
 Recurrence/progressive disease or death 2 4 7 13